Kidney cancer treatments and tumor biology can activate different immune-modifying processes in patients

The findings out of Dana-Farber Cancer Institute highlight that the mechanisms of immune modulation are different in patients treated with immunotherapy and anti-angiogenic combinations. The results also point to the role of tumor biology in the diversity and actions of tumor-infiltrating immune cells brought into action by these treatments. The findings might be important for predicting or understanding treatment outcomes in advanced kidney cancer.

UNC Lineberger named as a national research hub for NIH cancer screening study

UNC Lineberger Comprehensive Cancer Center has been selected as one of nine national research sites for the National Cancer Institute’s newly launched Cancer Screening Research Network, which will evaluate promising and emerging cancer screening technologies.

U of T-led study finds positive support from parents and clinicians for pediatric cancer pain management app

A recent study led by Assistant Professor Lindsay Jibb of the Lawrence Bloomberg Faculty of Nursing and Scientist at The Hospital for Sick Children (SickKids) found that parents of young children with cancer, along with pediatric cancer clinicians are in favour of an app-based solution that Jibb and her team are creating, to help parents manage their child’s cancer pain at home.

National Breast Cancer Foundation Gives Grant to Help Breast Care Center Patients at Texas Tech Physicians of El Paso

In addition to assisting with access to care, such as transportation and general needs like groceries, the grant will allow the Breast Care Center to screen for mental and emotional distress using tablets. Currently, patients participate in an online distress screening survey that prompts questions about financial and psychosocial stressors in a patient’s life.

In Memoriam: Jonathan W. Uhr, M.D., renowned immunologist and longtime Chair of Microbiology

Jonathan W. Uhr, M.D., Professor Emeritus of Immunology at UT Southwestern Medical Center, who discovered how antibodies are made and developed a technique that led to the early detection of cancer cells, died Feb. 15. He was 96. Dr. Uhr was a member of the National Academy of Sciences and the American Academy of Arts and Sciences.

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results from a clinical trial led by Queen Mary University of London.

Medical experts available for March: Colorectal Cancer Awareness, safe sleep & SIDS, returning to sports after injury, sleep aids, and habits to avoid for your brain health

As you plan healthcare coverage for March, Ochsner Health has experts on standby to cover several topics. Are younger people getting colorectal cancer?: Colorectal cancer has always been a cause for concern among middle-aged and older men and women. However,…

Clues to early onset colorectal cancer found in microbiome of Hispanic patients

Nina Sanford, M.D., Chief of Gastrointestinal Radiation Oncology Service, UT Southwestern Medical Center Most people have a screening colonoscropy around age 50, however recent research has uncovered a rise in early onset colorectal cancer in patients younger than 50. What can…

Chula Researcher’s Innovative Wireless Hepatitis B Test Kit for Complete Screening and Data Collection in One Step

Chula researchers have developed a remarkable wireless hepatitis B virus test kit to screen for infection and collect data for an online database that’s fast and complete in one step.

Sandalwood Oil By-product Prevents Prostate Cancer Development in Mice

Sandalwood oil has been used worldwide for centuries. Now, a study is the first to demonstrate in vivo the chemo-preventive properties of a by-product of the oil in a mouse model. Results show administering alpha-santalol reduced visible prostate tumors, protected the normal tissue, and delayed progression from a precancerous condition to a high-grade form of cancer. These findings are significant because mortality in prostate cancer patients is mainly attributable to advanced stages of the disease.

New Research Shows Patients with Cancer who Suffered a Major Adverse Financial Event More Likely to be Diagnosed With Advanced Stage Disease

New findings led by researchers at the American Cancer Society and the National Cancer Institute show more than one-third of cancer patients had a major adverse financial event – bankruptcy, lien, or eviction – before their cancer diagnosis.

$1.1M Grant Supports Research in Breast Cancer Survivorship among Black Women

Bo (Bonnie) Qin, PhD, researcher and cancer epidemiologist in the Section of Cancer Epidemiology and Health Outcomes at Rutgers Cancer Institute of New Jersey, has received $1.1M from the American Cancer Society to support her research on the impact of lifestyle patterns, social determinants of health, and inflammatory mechanisms on breast cancer survivorship among Black women.

Artificially intelligent software provides a detailed look at jets of plasma used to treat cancer

Artificially intelligent software has been developed to enhance medical treatments that use jets of electrified gas known as plasma. Developed by researchers at Princeton Plasma Physics Laboratory and the George Washington University, the computer code predicts the chemicals emitted by cold atmospheric plasma devices, which can be used to treat cancer and sterilize surfaces.

Expert Analysis: Black Americans Have Highest Cancer Mortality Rates In The United States

For Black History Month, Hackensack Meridian Health offers experts on some of the reasons behind higher cancer rates in the Black community and how to reverse the trends.

Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer

Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.